Target intelligence / Profile preview

Unknown senescence-related molecular targets

Molecular classification
Other
01

Overview

The term 'Unknown senescence-related molecular targets' refers to a broad and evolving category of molecular markers and therapeutic vulnerabilities in senescent cells that have not yet been fully characterized or identified as specific drug targets. Cellular senescence is a state of permanent cell cycle arrest that contributes to aging and age-related diseases through the secretion of pro-inflammatory factors, collectively known as the senescence-associated secretory phenotype (SASP). While several targets such as BCL-2, p16INK4a, and p21WAF1/CIP1 are well-established in the field of senolytics, research continues to uncover novel pathways that could be exploited to selectively eliminate senescent cells or modulate their harmful effects. This generic designation highlights the ongoing search for specific, druggable proteins that can serve as therapeutic anchors without affecting healthy tissue homeostasis. Consequently, this entry does not represent a single, well-defined therapeutic target but rather a research area focused on identifying new drivers of the senescent phenotype.

02

Mechanism of action

N/A

03

Biological functions

Cell cycleCell deathOther
04

Disease associations

CancerInflammationNeurodegenerative diseaseCardiovascular diseaseOther
05

Safety considerations

Off-target effects on healthy proliferating cellsPotential for impaired wound healingSystemic inflammation from SASP modulationLack of specificity for senescent cell types
06

Biomarkers

Senescence-associated beta-galactosidase (SA-β-gal)p16INK4ap21WAF1/CIP1Senescence-associated secretory phenotype (SASP) factorsLamin B1 loss

Beyond the preview

Go deeper on Unknown senescence-related molecular targets.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Unknown senescence-related molecular targets.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call